Connacht Asset Management’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,988
Closed -$477K 49
2023
Q2
$477K Sell
5,988
-7,267
-55% -$525K 0.65% 33
2023
Q1
$958K Sell
13,255
-6,381
-32% -$497K 0.41% 29
2022
Q4
$1.62M Buy
19,636
+1,535
+8% +$127K 0.73% 24
2022
Q3
$1.42M Sell
18,101
-15,023
-45% -$1.2M 1% 22
2022
Q2
$2.24M Buy
+33,124
New +$2.31M 0.94% 15

Other funds holding ACHC

Connacht Asset Management's ACHC Position: Q3 2023 in Review

Connacht Asset Management sold out of Acadia Healthcare (ACHC) in Q3 2023, closing a stake of 5,988 shares — an estimated $477K sold.

Connacht Asset Management first reported a position in ACHC in Q2 2022 and held it in 5 quarters. The position peaked at $2.24M in Q2 2022. 293 funds tracked by Wall St. Rank hold ACHC as of Q3 2023.

  • Connacht Asset Management reported no remaining Acadia Healthcare position as of Q3 2023 after selling out during the quarter.
  • Connacht Asset Management sold 5,988 Acadia Healthcare shares in Q3 2023, an estimated $477K.
  • Connacht Asset Management first reported a position in Acadia Healthcare in Q2 2022 and held it in 5 quarters.
  • Connacht Asset Management's Acadia Healthcare position peaked at $2.24M in Q2 2022.
  • 293 funds tracked by Wall St. Rank held Acadia Healthcare as of Q3 2023.

Based on Connacht Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.